Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENDO INTERNATIONAL PLC

(ENDP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Endo International plc Announces Board Changes

04/27/2021 | 04:15pm EDT

Endo International plc announced that Mark Barberio, who currently serves as an independent member of Endo's Board of Directors, has been appointed Chairman of the Board effective at the Company's 2021 Annual General Meeting. Mr. Barberio's appointment is part of Endo's ongoing Board succession process, which has also included adding two new Board members since the Company's 2020 Annual General Meeting. In addition, Paul Campanelli, who has served as Chairman of the Board since 2019 and who served as President and Chief Executive Officer from 2016 to 2020, will retire from the Board upon the expiration of his current term at the Company's 2021 Annual General Meeting. Finally, Roger Kimmel, who has been Senior Independent Director since 2019 and who served as Chairman of the Board from 2014 to 2019, will also retire from the Board upon the expiration of his current term. Mr. Barberio has been a member of the Board since February 2020. He has been a Principal of Markapital, LLC since May 2013 and currently serves as a Director of Gibraltar Industries Inc. and Life Storage Inc., where he has been Non-Executive Chairman since May 2018.


ę S&P Capital IQ 2021
All news about ENDO INTERNATIONAL PLC
05:09aEndo Announces First-Ever XIAFLEX (collagenase clostridium histolyticum) Television Com..
AQ
10/25ENDO INTERNATIONAL : Presents New XIAFLEX (collagenase clostridium histolyticum) Data Anal..
AQ
10/25ENDO INTERNATIONAL : Announces First-Ever XIAFLEX« (collagenase clostridium histolyticum) ..
PR
10/25Endo International plc Announces First-Ever XIAFLEX? (Collagenase Clostridium Histolyti..
CI
10/22ENDO INTERNATIONAL : Presents New XIAFLEX« (collagenase clostridium histolyticum) Data Ana..
PR
10/22Endo International plc Presents New XIAFLEX? (Collagenase Clostridium Histolyticum) Dat..
CI
10/21STRIDES PHARMA SCIENCE : Completes Acquisition of US-Based Endo International's Assets for..
MT
10/05ENDO INTERNATIONAL : to Announce Third Quarter 2021 Financial Results
PR
09/30ENDO INTERNATIONAL : California judge questions counties' opioid case against drugmakers a..
RE
09/30ENDO INTERNATIONAL : Says Research Shows Prescription Drug Xiaflex May be Appropriate to T..
MT
More news
Analyst Recommendations on ENDO INTERNATIONAL PLC
More recommendations
Financials (USD)
Sales 2021 2 787 M - -
Net income 2021 39,5 M - -
Net Debt 2021 6 718 M - -
P/E ratio 2021 7,18x
Yield 2021 -
Capitalization 1 023 M 1 023 M -
EV / Sales 2021 2,78x
EV / Sales 2022 2,66x
Nbr of Employees 3 397
Free-Float 98,5%
Chart ENDO INTERNATIONAL PLC
Duration : Period :
Endo International plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENDO INTERNATIONAL PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 4,38 $
Average target price 6,57 $
Spread / Average Target 50,0%
EPS Revisions
Managers and Directors
Blaise A Coleman President, Chief Executive Officer & Director
Mark Bradley Chief Financial Officer & Executive Vice President
Mark G. Barberio Chairman
Ruth Thorpe Chief Information Officer
Robert Polke Global Head-Operations